Claim Details

View detailed information about this claim and its related sources.

Back to Claims

Claim Information

Complete details about this extracted claim.

Claim Text
U.S prescription drug prices run more than 2.5 times those in 32 comparable countries, according to a 2023 HHS report.
Simplified Text
US prescription drug prices are more than 2.5 times those in 32 comparable countries according to a 2023 HHS report.
Confidence Score
0.900
Claim Maker
The author
Context Type
News Article
Context Details
{
    "date": "2023",
    "organization": "HHS"
}
UUID
9fdb1745-8e26-4c87-bba0-188f36a3f3a6
Vector Index
✗ No vector
Created
September 11, 2025 at 11:29 PM (5 days ago)
Last Updated
September 11, 2025 at 11:29 PM (5 days ago)

Original Sources for this Claim (1)

All source submissions that originally contained this claim.

Screenshot of https://www.usatoday.com/story/news/health/2024/12/15/why-americans-pay-more-for-health-care/76900978007/
https://www.usatoday.com/story/news/health/2024/12/15/why-americans-pay-more-for-health-care/76900978007/

High US healthcare costs stem from lack of price limits, fee-for-service payments, high specialist salaries, and excessive administrative costs. Prescription drug prices and private equity influence also contribute.

Healthcare Costs
US Healthcare System
Health Economics
Health Insurance
Prescription Drugs
Private Equity

Similar Claims (0)

Other claims identified as semantically similar to this one.

No similar claims found

This claim appears to be unique in the system.

Claim Management System - MVP